Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor
PNI and its dynamic changes may serve as useful indicators of prognosis in patients with ESCC receiving ICI-based therapies.
Authors
- Shota Fukuoka (ORCID: https://orcid.org/0000-0001-9460-4486)
- Akira Ooki (ORCID: https://orcid.org/0000-0001-7618-5775)
- S. Udagawa
- K. Chin
- Kei Yoshino (ORCID: https://orcid.org/0000-0002-8062-4379)
- Keitaro Shimozaki (ORCID: https://orcid.org/0000-0002-4559-5699)
- Hiroki Osumi (ORCID: https://orcid.org/0000-0002-4742-0446)
- Takeru Wakatsuki (ORCID: https://orcid.org/0000-0002-1463-3859)
- Eiji Shinozaki (ORCID: https://orcid.org/0000-0002-7448-5894)
- Mariko Ogura (ORCID: https://orcid.org/0000-0002-1004-8425)
- Kensei Yamaguchi (ORCID: https://orcid.org/0000-0001-6887-5709)
- Moritake Tamba
Institutions
- Japanese Foundation For Cancer Research (JP)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.esmogo.2025.100222
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00